Effect of climatic change in children with atopic eczema

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 61, Issue 12, 2006, Pages 1403-1410

  Byremo, G ^a,b   Rod G ^a   Carlsen, K H ^a,c  

^a UNIVERSITY OF OSLO   (Norway)

^b Sørlandet Sykehus HF Arendal ^*  (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Atopic eczema; Climate change; Quality of life; SCORing of Atopic Dermatitis; Serum eosinophilic cationic protein; Staphylococcus aureus; Sunlight

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; EOSINOPHIL CATIONIC PROTEIN; STEROID;

ADOLESCENT; ARTICLE; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CHILD; CLIMATE CHANGE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG POTENCY; FEMALE; FOLLOW UP; HUMAN; MALE; NORWAY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY OF LIFE INDEX; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STAPHYLOCOCCUS AUREUS; TROPICS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CLIMATE; DERMATITIS, ATOPIC; HUMANS; SEVERITY OF ILLNESS INDEX;

EID: 33750493918     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2006.01209.x     Document Type: Article

References (33)

1. Breuer K, Haussler S, Kapp A, Werfel T. Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br J Dermatol 2002;147:55-61.
2. Aberg N, Hesselmar B, Aberg B, Eriksson B. Increase of asthma, allergic rhinitis and eczema in Swedish schoolchildren between 1979 and 1991. Clin Exp Allergy 1995;25:815-819.
3. Wuthrich B, Schmid-Grendelmeier P. The atopic eczema/dermatitis syndrome. Epidemiology, natural course, and immunology of the IgE-associated ('extrinsic') and the nonallergic ('intrinsic') AEDS. J Investig Allergol Clin Immunol 2003;13:1-5.
4. Weiland SK, Husing A, Strachan DP, Rzehak P, Pearce N. Climate and the prevalence of symptoms of asthma, allergic rhinitis, and atopic eczema in children. Occup Environ Med 2004;61:609-615.
5. Steen-Johnsen J, Bolle R, Holt J, Benan K, Magnus P. Impact of pollution and place of residence on atopic diseases among schoolchildren in Telemark County, Norway. Pediatr Allergy Immunol 1995;6:192-199.
6. Dotterud LK, Kvammen B, Bolle R, Falk ES. A survey of atopic diseases among school children in Sor-Varanger community. Possible effects of subarctic climate and industrial pollution from Russia. Acta Derm Venereol 1994;74:124-128.
7. Hesselmar B, Aberg B, Eriksson B, Aberg N. Allergic rhinoconjunctivitis, eczema, and sensitization in two areas with differing climates. Pediatr Allergy Immunol 2001;12:208-215.
8. Ben-Gashir MA, Seed PT, Hayt RJ. Are quality of family life and disease severity related in childhood atopic dermatitis? J Eur Acad Dermatol Venereol 2002;16:455-462.
9. Kiebert G, Sorensen SV, Revicki D, Fagan SC, Doyle JJ, Cohen J et al. Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol 2002;41:151-158.
10. Yoshimura-Mishima M, Akamtsu H, Namura S, Horio T. Suppressive effect of ultraviolet (UVB and UVB) radiation on superantigen production by Staphylococcus aureus. J Dermatol Sci 1999;19:31-36.
11. Abeck D, Schmidt T, Fesq H, Strom K, Mempel M, Brockow K et al. Long-term effcacy of medium-dose UVA1 phototherapy in atopic dermatitis. J Am Acad Dermatol 2000;42(2 Pt 1):254-257.
12. Purschel W. Dermatological climatotherapy on the North Sea. Clinical-analytical studies of constitutional eczematoid with - without bronchial asthma and - or atopic rhinitis. Dermatologica 1973;146(Suppl. 1):1-98.
13. Harari M, Shani J, Seidl V, Hristakieva E. Climatotherapy of atopic dermatitis at the Dead Sea: demographic evaluation and cost-effectiveness. Int J Dermatol 2000;39:59-69.
14. Menger W. Indications and successes of climate therapy of children. Offentl Gesundheitswes 1989;51:470-476.
15. Autio P, Komulainen P, Larni HM. Heliotherapy in atopic dermatitis: a prospective study on climatotherapy using the SCORAD index. Acta Derm Venereol 2002;6:436-440.
16. Severity SCORing of Atopic Dermatitis: the SCORAD Index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993;186:23-31.
17. Sosial-og helsedepartementet (Norway). Behandlingsreiser til utlandet. Et offentlig ansvar: NOU, Norges offentlige utredninger, 2002:2.
18. Mork C, Wahl A. Improved quality of life among patients with psoriasis after supervised climate therapy at the Canary Islands. J Am Acad Dermatol 2002;47:314-316.
19. Rodt A. Atopisk eksem - sol og saltvann. Allergi i praksis 1997;3:43-48.
20. Dreborg S, Frew A. Allergen standardization and skin tests. Allergy 1993;48(Suppl. 14):48-82.
21. Dahl R, Venge P, Olsson J. Blood eosinophil leukocytes and eosinophil cationic protein: diurnal variation in normal subjects and in patients with bronchial asthma. Scand J Respir Dis 1978;59:323-325.
22. Peterson CGB, Enander I, Nyshand J, Andersson AS, Nilsson L, Venge P. Radioimmunoassay of eosinophil cationic protein (ECP) by an improved method: establishment of normal levels in serum and turnover in vivo. Clin Exp Allergy 1991;21:561-567.
23. Gutgesell C, Heise S, Seubert A, Stichtenoth DO, Frolich JC, Nuemann C. Comparison of different activity parameters in atopic dermatitis: correlation with clinical scores. Br J Dermatol 2002;147:914-919.
24. Lewis-Jones MS, Finlay AY. The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol 1995;132:942-949.
25. Herd RM, Tidman MJ, Ruta DA, Hunter JAA. Measurement of quality of life in atopic dermatitis. Br J Dermatol 1997;136:502-507.
26. Oranje AP, Stalder JF, Taieb A, Tasset C, de Loungeville M. SCORing of Atopic Dermatitis by SCORAD using a training atlas by investigators from different disciplines. ETAC Study group. Early treatment of the atopic child. Pediatr Allergy Immunol 1997;8:28-34.
27. Amon U, Memmel U, Stoll R, Amon S. Comparison of severity SCORing of Atopic Dermatitis values and serum levels of eosinophil cationic protein and mast cell tryptase for routine evaluation of atopic dermatitis. Acta Derm Venereol 2000;80:284-286.
28. Carlsen KH, Halvorsen R, Pettersen M, Carlsen KCL. Inflammation markers and symptom activity in children with bronchial asthma. Influence of atopy and eczema. Pediatr Allergy Immunol 1997;8:112-120.
29. Reynolds NJ, Franklin V, Gray JC, Diffey BL, Farr PM. Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial. Lancet 2001;357:2012-2016.
30. Tzaneva S, Seeber A, Schwaiger M, Honigsmann H, Tanew A. High-dose vs medium-dose UVA1 phototherapy for patients with severe generalized atopic dermatitis. J Am Acad Dermatol 2001;45:503-507.
31. Cooper KD. Cell-mediated immunosuppresive mechanisms induced by UV-radiation. Photochem Photobiol 1996;63:400-406.
32. Heck DE, Gerecke DR, Vetrano AM, Laskin JD. Solar ultraviolet radiation as a trigger of cell signal transduction. Toxicol Appl Pharmacol 2004;195:288-297.
33. Akiyama H, Yamasaki O, Kanzaki H, Tada J, Arata J. Effects of various salts and irradiation with UV light on the attachment of Staphylococcus aureus strains. J Dermatol Sci 1998;16:216-225.